FA
Insider selling
Fred Aslan sold $690K of Artiva Biotherapeutics, Inc. (ARTV) stock
Fred Aslan, Chief Executive Officer of Artiva Biotherapeutics, Inc. (ARTV), sold 61,888 shares of ARTV stock worth $690K, per an SEC Form 4 filed Sep 4, 2026.
It was an open-market sale.
The trade happened on Sep 3, 2026, 1 day before it was made public.
ARTV has moved -39.1% since the trade date, from $11.13 to $6.77 (Oct 12, 2026 close).
- Traded
- Sep 3, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 1 day
- Price since
- -39.1%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More ARTV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.